Securities code: Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) securities abbreviation: Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) Announcement No.: 2022009 Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) the Fourth Board of supervisors
Announcement of resolutions of the 13th meeting
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. 1、 Meetings of the board of supervisors
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) (hereinafter referred to as “the company”) the notice of the 13th meeting of the 4th board of supervisors was sent to all supervisors by email and telephone on February 24, 2022. The meeting was held in the company’s conference room in the form of on-site meeting and communication on March 2, 2022. The meeting was convened and presided over by Mr. Liu Lijian, chairman of the board of supervisors of the company. There were 3 supervisors who should attend the meeting, 3 supervisors who actually attended the meeting, and Mr. Chen Yu attended the meeting of the board of supervisors by means of communication voting. The convening, convening and voting of this meeting comply with the provisions of the company law and other relevant laws, regulations, normative documents and the articles of association. The meeting is legal and effective. 2、 Deliberation at the meeting of the board of supervisors
1. Proposal on using some over raised funds to invest in the project of expanding the production capacity of pre filled medical packaging materials
After deliberation, it is agreed that the company will initiate Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) investment to expand the production capacity of pre filled medical packaging materials under the background of enterprise strategic development. The estimated total investment is 300 million yuan (the final total investment of the project is subject to the actual investment). It is proposed to use part of the over raised funds to invest in the project.
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the company’s disclosure on cninfo.com on the same day（ http://www.cn.info.com.cn. ）Announcement on using some over raised funds to invest in the project of expanding the production capacity of pre filled medical packaging materials.
This proposal needs to be submitted to the second extraordinary general meeting of shareholders of the company in 2022 for deliberation. 2. Proposal on general election of the board of supervisors and nomination of candidates for shareholders’ representative supervisors of the Fifth Board of supervisors
Since the term of office of the Fourth Board of supervisors of the company has expired, according to the articles of association and relevant laws and regulations, the board of supervisors of the company needs to be replaced and the members of the new board of supervisors shall be elected. The 4th board of supervisors of the company nominated Ms. Hu Jing as the candidate of shareholder representative supervisor of the 5th board of supervisors. The term of office of the Fifth Board of supervisors is three years, from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the term of office of the Fifth Board of supervisors.
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the company’s disclosure on cninfo.com on the same day（ http://www.cn.info.com.cn. ）Announcement on the general election of the board of supervisors.
This proposal needs to be submitted to the second extraordinary general meeting of shareholders of the company in 2022 for deliberation. 3、 Documents for future reference
1. Resolution of the 13th meeting of Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) the 4th board of supervisors
2. Other documents required by Shenzhen Stock Exchange
It is hereby announced.
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) board of supervisors
March 3, 2022
